RELIW vs RMD · rev $14.1M vs P/E 29, rev $5.65B
Reliance Global Group Inc (RELIW) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
Reliance Global Group Inc (RELIW) common stock listed on NASDAQ.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported RELIW revenue for 2024-12-31 was $14.1M. Net income was -$9.1M. Revenue was up 2.3% from 2023-12-31 to 2024-12-31. RELIW currently screens at market cap $39.2M.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
RELIW currently screens at market cap $39.2M. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the RELIW and RMD stock pages for the full models.
Not investment advice.